Jung-yun Lee
Liege, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Journal: The New England journal of medicine
Published: July 03, 2024
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Journal: The New England journal of medicine
Published: December 06, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026